Brian Deagon, senior reporter at Investor's Business Daily, says he understands why the Tesla CEO would be agitated by short sellers and hearing the same questions about production and cash flow every quarter. For full interview, [click here](https://cheddar.com/videos/musks-tweetstorm-following-bizarre-earnings-call).

Share:
More In Business
Biogen Lowers Full-Year Profit Forecast
Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Load More